Pain
Topics
Extended-Release vs Sublingual Buprenorphine for Adolescent Opioid Use Disorder (ERA) (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
Low-threshold Buprenorphine Treatment at Syringe Services Programs: a Type I Hybrid Effectiveness-implementation Trial
Funded by the NIH HEAL Initiative℠
Rural Expansion of Medication Treatment for Opioid Use Disorder: Electronic Health Record Data Collection and Analysis (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the treatment of opioid use disorder: A pragmatic, multi-site, double-blind, Randomized, placebo-controlled, trial (TAB) (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative℠
Rural Expansion of Medication Treatment for Opioid Use Disorder: Randomized Controlled Pilot Trial of Extended-release Buprenorphine vs. Sublingual Buprenorphine-naloxone in Rural Settings (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
Barriers and Facilitators to Engaging in Addiction Treatment among Black, Latino, and non-Latino White Patients Receiving ED-initiated Buprenorphine Treatment (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
Adolescent outcomes of Post-operative opioid Exposure (APEX) (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
Adherence and Feasibility of Wearable Technologies and Ecological Momentary Assessment to Assess Autonomic Function and Negative Affect in Opioid Use Disorder (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative℠
Ancillary Study of the Adoption and Sustainability of ED-Initiated Buprenorphine (NIH Heal Initiative)
Funded by the NIH HEAL Initiative®
Harnessing Digital Health to Understand Clinical Trajectories of Opioid Use Disorder (D-TECT) (NIH HEAL Initiative)
Funded by the NIH HEAL Initiative®
This is an observational study designed to (1) evaluate the feasibility and utility of digital health technology in a MOUD treatment population, and (2) capitalize on the availability of EHR data to relate passive and active sensing data to treatment retention and medication adherence.
Lisa A. Marsch, Ph.D.
Professor, Department of Psychiatry; Director, Center for Technology and Behavioral Health; Director, Dartmouth Psychiatric Research Center
Geisel School of Medicine at Dartmouth College